A national survey of adverse event for buccal midazolam as prehospital treatment
-
- Hoshide Madoka
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Yamaguchi University, Ube, Yamaguchi
-
- Korematsu Seigo
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Saitama Medical Center Saitama Medical University, Kawagoe, Saitama
-
- Ito Susumu
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Tokyo Women’s Medical University, Tokyo
-
- Shimokawa Shoko
- Medical Safety Committee, Japanese Society of Child Neurology Department of Neurosurgery, Kurume University School of Medicine, Kurume, Fukuoka
-
- Miyata Rie
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Tokyo-kita Medical Center, Tokyo
-
- Ihara Satoshi
- Medical Safety Committee, Japanese Society of Child Neurology Department of Neurosurgery, Tokyo Metropolitan Children’s Medical Center, Fuchu, Tokyo
-
- Ishii Mitsuko
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Chiba Rehabilitation Center, Chiba
-
- Watanabe Yoshihiro
- Medical Safety Committee, Japanese Society of Child Neurology Children’s Medical Center, Yokohama City University Medical Center, Yokohama, Kanagawa
-
- Fukui Miho
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka
-
- Sato Tatsuharu
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Nagasaki University Hospital, Nagasaki
-
- Morimoto Noriko
- Medical Safety Committee, Japanese Society of Child Neurology Department of Otolaryngology, National Center for Child Health and Development, Tokyo
-
- Miyamoto Yusaku
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Kanagawa
-
- Mimaki Masakazu
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Teikyo University School of Medicine, Tokyo
-
- Yamanaka Gaku
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo
-
- Yamanouchi Hideo
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Saitama Medical University, Kawagoe, Saitama
-
- Muramatsu Kazuhiro
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Jichi Medical University, Shimotsuke, Tochigi
-
- Takeshima Yasuhiro
- Medical Safety Committee, Japanese Society of Child Neurology Department of Pediatrics, Hyogo Medical University School of Medicine, Nishinomiya, Hyogo
Bibliographic Information
- Other Title
-
- 病院前治療におけるmidazolam口腔用液使用の有害事象に関する全国調査
Abstract
<p> A questionnaire survey was conducted among members of the Japanese Society of Pediatric Neurology regarding adverse events with oral solution of midazolam (buccal MDL) used as prehospital treatment for status epilepticus. A total of 431 respondents were surveyed (12.0% responded). Of 580 patients treated with buccal MDL, 14 (2.4%) had adverse events (respiratory depression, falls and trauma due to dizziness, sedation for more than 1 hour). 7 of the 14 cases were due to respiratory depression. Respiratory depression should be considered as an adverse event when buccal MDL is administered for status epilepticus.</p>
Journal
-
- NO TO HATTATSU
-
NO TO HATTATSU 56 (2), 145-147, 2024
The Japanese Society of Child Neurology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390862389985242112
-
- ISSN
- 18847668
- 00290831
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
-
- Abstract License Flag
- Disallowed